Literature DB >> 7943401

Role of rostral ventrolateral medulla in centrally mediated pressor responses.

J M Kiely1, F J Gordon.   

Abstract

The region of the rostral ventrolateral medulla (RVLM) plays an important role in central nervous system regulation of cardiovascular function. The initial purpose of these studies was to determine whether synaptic activation of excitatory amino acid (EAA) receptors in the RVLM might mediate central pressor responses. Blockade of EAA receptors in the RVLM with kynurenic acid abolished pressor responses evoked by stimulation of sciatic nerve afferents but had no effect on increases in arterial pressure produced by stimulation of hypothalamic sites. To determine whether synaptic transmission in the RVLM, independent of EAA receptor activation, was a prerequisite for the production of hypothalamic pressor responses, axonal conduction and/or synaptic transmission were pharmacologically interrupted in the RVLM. Blockade of synaptic transmission with muscimol or kainic acid attenuated, but did not eliminate, hypothalamic pressor responses. Concurrent blockade of synaptic and axonal transmission in the RVLM with lidocaine produced the greatest reduction of hypothalamic pressor responses. Collectively, these results suggest that central pressor responses are not uniformly mediated by synaptic activation of neurons within the RVLM. Instead, a combination of synaptic transmission and axonal conduction within and possibly outside the region of the RVLM may be required for the production of many centrally mediated pressor responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943401     DOI: 10.1152/ajpheart.1994.267.4.H1549

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Is visceral sympathoexcitation to heat stress dependent on activation of ionotropic excitatory amino acid receptors in the rostral ventrolateral medulla?

Authors:  M J Kenney; C N Meyer; K G Hosking; R J Fels
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-01       Impact factor: 3.619

Review 2.  Rostral ventrolateral medulla: an integrative site for muscle vasodilation during defense-alerting reactions.

Authors:  Sergio L Cravo; Olga S Possas; Marcos L Ferreira-Neto
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 3.  Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla.

Authors:  Alan F Sved; Satoru Ito; Judith C Sved
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

4.  (In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity.

Authors:  Nicholas A Mischel; Patrick J Mueller
Journal:  J Appl Physiol (1985)       Date:  2011-10-06

Review 5.  Animal aging and regulation of sympathetic nerve discharge.

Authors:  Michael J Kenney
Journal:  J Appl Physiol (1985)       Date:  2010-07-22

6.  Disinhibition of RVLM neural circuits and regulation of sympathetic nerve discharge at peak hyperthermia.

Authors:  Michael J Kenney; Chanran K Ganta; Richard J Fels
Journal:  J Appl Physiol (1985)       Date:  2013-08-29

7.  RVLM glycine receptors mediate GABAA and GABAB)independent sympathoinhibition from CVLM in rats.

Authors:  Cheryl M Heesch; Jennifer D Laiprasert; Lyudmyla Kvochina
Journal:  Brain Res       Date:  2006-11-16       Impact factor: 3.252

8.  Discharge of RVLM vasomotor neurons is not increased in anesthetized angiotensin II-salt hypertensive rats.

Authors:  Gustavo R Pedrino; Alfredo S Calderon; Mary Ann Andrade; Sergio L Cravo; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-11       Impact factor: 4.733

9.  Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.

Authors:  Domitila A Huber; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

10.  The gigantocellular depressor area revisited.

Authors:  Sue A Aicher
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.